Daye M, Uygun H. Papillary Thyroid Carcinoma in a Patient with Psoriasis Treated with Secukinumab. Dermatology Review/Przegląd Dermatologiczny. 2026;113(1):50-53. doi:10.5114/dr.2026.161419.
APA
Daye, M., & Uygun, H. (2026). Papillary Thyroid Carcinoma in a Patient with Psoriasis Treated with Secukinumab. Dermatology Review/Przegląd Dermatologiczny, 113(1), 50-53. https://doi.org/10.5114/dr.2026.161419
Chicago
Daye, Munise, and Hilmi Uygun. 2026. "Papillary Thyroid Carcinoma in a Patient with Psoriasis Treated with Secukinumab". Dermatology Review/Przegląd Dermatologiczny 113 (1): 50-53. doi:10.5114/dr.2026.161419.
Harvard
Daye, M., and Uygun, H. (2026). Papillary Thyroid Carcinoma in a Patient with Psoriasis Treated with Secukinumab. Dermatology Review/Przegląd Dermatologiczny, 113(1), pp.50-53. https://doi.org/10.5114/dr.2026.161419
MLA
Daye, Munise et al. "Papillary Thyroid Carcinoma in a Patient with Psoriasis Treated with Secukinumab." Dermatology Review/Przegląd Dermatologiczny, vol. 113, no. 1, 2026, pp. 50-53. doi:10.5114/dr.2026.161419.
Vancouver
Daye M, Uygun H. Papillary Thyroid Carcinoma in a Patient with Psoriasis Treated with Secukinumab. Dermatology Review/Przegląd Dermatologiczny. 2026;113(1):50-53. doi:10.5114/dr.2026.161419.
